Financing, Equity Capital Markets

Aquestive Therapeutics, Inc.

03/24
|
$75.0 Million
Aquestive Therapeutics, Inc.
Piper Sandler served as bookrunner for Aquestive Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma